Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. (ITI) is a privately held development-stage biotechnology company. It is principally engaged in developing vaccines and vaccine immunotherapies. The company products are specially designed for treating allergies, HIV and cancers. It uses LAMP ((Lysosome-Associated Membrane Protein) technology to develop its vaccines. Currently, ITI has four vaccines under development. The company operates along with partners, including Geron Corporation, Althea, Nature Pharmaceuticals, NeoVax, Genoa Biotechnologia, S.A. and Ichor Medical Systems. Genoa Biotechnologia, S.A. collaborates with ITI to develop a therapeutic HIV vaccine, namely, Argotom-VAX. ITI is headquartered in Maryland, the US.